Direct costs of antineoplastic and supportive treatment for progressive multiple myeloma in a tax-based health system

Research output: Contribution to journalJournal articleResearchpeer-review

Original languageEnglish
JournalFuture Oncology
Volume17
Issue number25
Pages (from-to)3331-3341
Number of pages11
ISSN1479-6694
DOIs
Publication statusPublished - Sep 2021

Keywords

  • antineoplastic agents
  • healthcare costs
  • micro-costing
  • multiple myeloma
  • supportive care

Fingerprint

Dive into the research topics of 'Direct costs of antineoplastic and supportive treatment for progressive multiple myeloma in a tax-based health system'. Together they form a unique fingerprint.

Cite this